Production (Stage)
Genesis Healthcare, Inc.
GENN
$0.0002
$0.000.00%
OTC PK
| 12/31/2020 | 09/30/2020 | 06/30/2020 | 03/31/2020 | 12/31/2019 | |
|---|---|---|---|---|---|
| Revenue | 3.91B | 4.12B | 4.31B | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.91B | 4.12B | 4.31B | -- | -- |
| Cost of Revenue | 2.26B | 2.33B | 2.41B | -- | -- |
| Gross Profit | 1.65B | 1.79B | 1.89B | -- | -- |
| SG&A Expenses | 594.51M | 593.40M | 601.21M | -- | -- |
| Depreciation & Amortization | 107.83M | 105.94M | 116.50M | -- | -- |
| Other Operating Expenses | 1.22B | 1.28B | 1.30B | -- | -- |
| Total Operating Expenses | 4.18B | 4.30B | 4.43B | -- | -- |
| Operating Income | -269.78M | -180.60M | -125.90M | -- | -- |
| Income Before Tax | -106.98M | -102.55M | 51.53M | -- | -- |
| Income Tax Expenses | -3.61M | 1.37M | 629.00K | -- | -- |
| Earnings from Continuing Operations | -103.37 | -103.92 | 50.90 | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 44.40M | 41.24M | -4.70M | -- | -- |
| Net Income | -58.96M | -62.69M | 46.20M | -- | -- |
| EBIT | -269.78M | -180.60M | -125.90M | -- | -- |
| EBITDA | -161.94M | -74.66M | -9.40M | -- | -- |
| EPS Basic | -0.52 | -0.55 | 0.43 | -- | -- |
| Normalized Basic EPS | -1.80 | -1.31 | -1.52 | -- | -- |
| EPS Diluted | -0.59 | -0.68 | 0.28 | -- | -- |
| Normalized Diluted EPS | -1.73 | -1.24 | -1.32 | -- | -- |
| Average Basic Shares Outstanding | 447.39M | 443.48M | 439.46M | -- | -- |
| Average Diluted Shares Outstanding | 505.08M | 501.17M | 554.03M | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |